Skip to content

Eye-masks and earplugs as sleep aids to reduce blood pressure in pregnancy

Eye-masks and earplugs as sleep aids to reduce blood pressure in pregnancy: A randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50371534
Enrollment
140
Registered
2023-02-17
Start date
2023-03-07
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-hypertension in late pregnancy in mothers with sleep deprivation Pregnancy and Childbirth

Interventions

This is an interventional randomized controlled study in which participants will be assigned by a computer (only revealed after the opening of an envelope after mothers consent to participate) into tw

Sponsors

University Malaya Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Blood pressure within suboptimal/pre-hypertension range (systolic 120-139 and/or diastolic 80-89 mmHg) 2. Self-reported sleep of less than 6 hours 3. Gestation 34-36 weeks 4. Age more or equal to 18 years old 5. Singleton pregnancy

Exclusion criteria

Exclusion criteria: 1. Anticipated delivery in the next week 2. Significant visual and/or hearing impairment 3. On antihypertensives for gestational hypertension or chronic hypertension 4. Known sleep disorders: Chronic insomnia, sleep apnoea 5. Known psychiatric disorders: Depression, schizophrenia etc. 6. Known major medical disorders: Diabetic Mellitus type 1 or 2, SLE, thyroid disorders, epilepsy, heart diseases etc. 7. Inability/unwillingness to use an eye mask and earplugs 8. Inability/unwillingness to use ActiGraph wGT3X-BT device 9. BMI >35 10. Active smoker 11. Current alcohol consumption 12. Multipara with co-sleeping child/children 13. Night shift workers 14. Night caretaker of other family members 15. Gross fetal anomalies 16. Intrauterine fetal death

Design outcomes

Primary

MeasureTime frame
1. Systolic blood pressure measured using an automated blood pressure machine from recruitment to during the intervention period 2. Diastolic blood pressure measured using an automated blood pressure machine from recruitment to during the intervention period

Secondary

MeasureTime frame
Maternal outcome: 1. Mean arterial pressure measured using an automated blood pressure machine from recruitment to during the intervention period 2. Pregnancy-induced hypertension (systolic BP = 140 and/or diastolic = 90 mmHg) on 2 occasions at least 4 hours measured using an automated blood pressure machine apart during the intervention period 3. Actigraphy derived-night sleep duration measured using data recorded in the watch app during the intervention period 4. Sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) at recruitment and at the end of the intervention period 5. Pregnancy outcome measured using data recorded in patient medical notes: 5.1. Labour induction 5.2. Mode of delivery 5.3. Peri-delivery blood loss Neonatal outcome measured using data recorded in patient medical notes after birth: 1. Birth weight 2. Cord arterial blood pH and base excess 3. Health evaluation measured using APGAR scoring at 1 and 5 minutes after birth 4. Neonatal intensive care unit (NICU) admission

Countries

Malaysia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026